{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:14:45Z","timestamp":1775693685268,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.02.032","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T19:27:28Z","timestamp":1583868448000},"page":"3351-3357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers"],"prefix":"10.1016","volume":"38","author":[{"given":"Cristina","family":"Carias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Hills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishwa B.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.032_b0005","unstructured":"Hills SL, Rabe IB, Fischer M. Japanese encephalitis. In: Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press, 2017:214\u201323."},{"key":"10.1016\/j.vaccine.2020.02.032_b0010","doi-asserted-by":"crossref","unstructured":"Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011; 89: 766\u201374, 74A\u201374E.","DOI":"10.2471\/BLT.10.085233"},{"key":"10.1016\/j.vaccine.2020.02.032_b0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973\u20132008","volume":"82","author":"Hills","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.02.032_b0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2020.02.032_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2020.02.032_b0030","first-page":"143","article-title":"Cost benefit analysis of Japanese encephalitis vaccination program in Thailand","volume":"28","author":"Siraprapasiri","year":"1997","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2020.02.032_b0035","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2010.04.086","article-title":"A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia","volume":"28","author":"Touch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0040","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1016\/j.vaccine.2012.05.068","article-title":"An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China","volume":"30","author":"Yin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jtm.12020","article-title":"A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine","volume":"20","author":"Duffy","year":"2013","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.02.032_b0050","unstructured":"Annual Number of Trips by Air by US Citizens to Asia. http:\/\/travel.trade.gov\/ (accessed May 9, 2019)."},{"key":"10.1016\/j.vaccine.2020.02.032_b0055","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0060","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2019.03.030","article-title":"Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO\u00ae in healthy adults: a five year follow-up study","volume":"37","author":"Taucher","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0065","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1016\/j.vaccine.2015.05.037","article-title":"Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis","volume":"33","author":"Paulke-Korinek","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.vaccine.2014.11.046","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009\u20132012","volume":"33","author":"Rabe","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0075","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2018.04.038","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012\u20132016","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.13-0206","article-title":"Initial and long-term costs of patients hospitalized with West Nile virus disease","volume":"90","author":"Staples","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.02.032_b0085","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.vaccine.2016.11.078","article-title":"Cost effectiveness of a targeted age-based West Nile virus vaccination program","volume":"35","author":"Shankar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0090","unstructured":"Historical Consumer Price Index for All Urban Consumers - Medical Care Component, 1982-84=100. Bureau of Labor Statistics. https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu. (accessed May 9, 2019)."},{"key":"10.1016\/j.vaccine.2020.02.032_b0095","unstructured":"Historical Consumer Price Index for All Urban Consumers, US-All Items, 1982-84=100. Bureau of Labor Statistics. https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu (accessed May 9, 2019)."},{"key":"10.1016\/j.vaccine.2020.02.032_b0100","first-page":"1","article-title":"Estimated annual and lifetime labor productivity in the United States implications for economic evaluations","volume":"2018","author":"Grosse","year":"2016","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.vaccine.2020.02.032_b0105","unstructured":"IBM Micromedex\u00ae. RED BOOK Online. Truven Health Analytics. Available at www.micromedexsolutions.com. (accessed April 28, 2019)."},{"key":"10.1016\/j.vaccine.2020.02.032_b0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.vaccine.2004.07.028","article-title":"Estimating medical practice expenses from administering adult influenza vaccinations","volume":"23","author":"Coleman","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.032_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2334-9-65","article-title":"Effectiveness and economic analysis of the whole cell\/recombinant B subunit (WC\/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea","volume":"9","author":"L\u00f3pez-Gigosos","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.032_b0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1708-8305.2008.00270.x","article-title":"Cost-benefit of WC\/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea","volume":"16","author":"Lundkvist","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.02.032_b0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bmj.309.6959.918","article-title":"Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers","volume":"309","author":"Behrens","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.02.032_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/JOM.0000000000001474","article-title":"Analysis of the full economic cost for Japanese encephalitis under different risk scenarios for business travelers to Asia","volume":"61","author":"Rogers","year":"2019","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.vaccine.2020.02.032_b0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4269\/ajtmh.14-0062","article-title":"Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet","volume":"91","author":"Deshpande","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.02.032_b0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6745a4","article-title":"Updated framework for development of evidence-based recommendations by the Advisory Committee on Immunization Practices","volume":"67","author":"Lee","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.02.032_b0145","unstructured":"Japanese Encephalitis Vaccine Evidence to Recommendations Framework. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/JE-etr-framework.html. Accessed January 29, 2020."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:07Z","timestamp":1759401727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20302292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20302292"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}